145
Participants
Start Date
February 28, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
TC-5214
Tablet, oral, twice daily for 8 weeks
Duloxetine
Capsule, oral, once daily
Placebo
Tablet, oral, twice daily for 8 weeks
Research Site, Beverly Hills
Research Site, Chino
Research Site, Garden Grove
Research Site, San Diego
Research Site, Torrance
Research Site, Bradenton
Research Site, Coral Springs
Research Site, Jacksonville
Research Site, North Miami
Research Site, St. Petersburg
Research Site, West Palm Beach
Research Site, Atlanta
Research Site, Joliet
Research Site, Prairie Village
Research Site, Flowood
Research Site, New York
Research Site, Rochester
Research Site, Dayton
Research Site, Mason
Research Site, Portland
Research Site, Allentown
Research Site, Dallas
Research Site, Houston
Research Site, Seattle
Research Site, Madison
Research Site, Tallinn
Research Site, Tartu
Research Site, Helsinki
Research Site, Jyväskylä
Research Site, Kuopio
Research Site, Tampere
Research Site, Visakhapatnam
Research Site, Ahmedabad
Research Site, Bangalore
Research Site, Bangalore
Research Site, Mangalore
Research Site, Nashik
Research Site, Jaipur
Research Site, Chennai
Research Site, Varanasi
Research Site, Kanpur
Research Site, Pune
Research Site, Nagoya
Research Site, Ichikawa
Research Site, Noda
Research Site, Fukuoka
Research Site, Omuta
Research Site, Sapporo
Research Site, Sapproro
Research Site, Akashi
Research Site, Kobe
Research Site, Kawasaki-shi
Research Site, Sagamihara-shi
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Yatsushiro
Research Site, Ukyo-ku ,Kyoto
Research Site, Kurashiki-shi
Research Site, Kodaira-shi
Research Site, Meguro-ku
Research Site, Minato-ku
Research Site, Setagaya-ku
Research Site, Shinagawa-ku
Lead Sponsor
AstraZeneca
INDUSTRY